-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/impaired-visual-acuity-screening-older-adults
May 24, 2022 - Four randomized trials (n = 4819) studied the difference between vision screening in primary care–applicable
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/XGHwLrLfb_78ymEUwGF6jR
March 19, 2024 - Primary Care Interventions to Prevent Child Maltreatment: Evidence Report and Systematic Review for the US Preventive Services Task Force
Primary Care Interventions to Prevent Child Maltreatment
Evidence Report and Systematic Review
for the US Preventive Services Task Force
Meera Viswanathan, PhD; Caroline Rains, MPH…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hepatitis-b-virus-infection-screening
December 15, 2020 - HBeAg; anti-HBs, antibody to HBsAg; HBV, hepatitis B virus; HR, hazard ratio; KQ, key question; NA, not applicable
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/child-maltreatment-counseling-2004
March 09, 2004 - Studies included in this review had English-language abstracts, were applicable to U.S. clinical practice … written questionnaires or other assessment procedures, such as physical examinations, that were brief and applicable
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/qCaKmh7ayuG9VP2vj646pQ
March 01, 2004 - Studies included in this review had English-
language abstracts, were applicable to U.S. clinical
practice … written
questionnaires or other assessment procedures,
such as physical examinations, that were brief and
applicable
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary52/vitamin-d-and-calcium-to-prevent-fractures-preventive-medication-2013
December 10, 2011 - Quality item “<20% loss to follow-up” was applicable only to prospective cohort studies (total cancer … 1.02–1.34)
25-(OH)D = 25-hydroxyvitamin D; HR = hazard ratio; KQ = key question; NA = not applicable
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-supplemental-screening-in-women-with-dense-/breast-cancer-screening-january-2016
January 11, 2016 - mean) †
Dense breasts: 100%
Personal history: NR
Family history: NR
NA = not applicable
-
www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/asymptomatic-bacteriuria-in-adults-screening
September 24, 2019 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Final Recommendation Statement
Asymptomatic Bacteriuria in Adults: Screening
September 24, 2019
Recommendations made by the USPSTF are independent of the U.S. government. They …
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prostate-cancer-screening
May 08, 2018 - Active surveillance in ProtecT consisted chiefly of PSA monitoring, which may not be applicable to US … Active surveillance in ProtecT consisted chiefly of PSA monitoring, which may not be applicable to US
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/LgBN7_z7hqynt6BRzUUYA-
February 01, 2009 - Screening for Skin Cancer: An Update of the Evidence
Clinical Guidelines Annals of Internal Medicine
Screening for Skin Cancer: An Update of the Evidence for the U.S.
Preventive Services Task Force
Tracy Wolff, MD, MPH; Eric Tai, MD, MS; and Therese Miller, DrPH
Background: Skin cancer is the most commonly dia…
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary20/suicide-risk-in-adolescents-adults-and-older-adults-screening
April 15, 2013 - ; DSH = deliberate self-harm; ED = emergency department; GDS = Geriatric Depression Scale; NA = not applicable … emergency department; GP = general practitioner; HADS = Hospital Anxiety and Depression Scale; NA = not applicable
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/JcwfLrEqaaxP6DPEQvxgUs
February 18, 2020 - The most directly applicable
body of evidence for patients without a history of CVD demonstrates benefits … However, the most directly applicable body of evidence for pa-
tients without a history of CVD demonstrates
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction
September 03, 2019 - thrombosis; ER−, estrogen receptor–negative; ER+, estrogen receptor–positive; KQ, key question; NA, not applicable … receptor–positive; ER−, estrogen receptor–negative; KQ, key question; LCIS, lobular carcinoma in situ; NA, not applicable
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/child-maltreatment-primary-care-interventions-november-2018
November 27, 2018 - Children with signs or symptoms suggestive of maltreatment should be assessed or reported according to the applicable
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/R33bUm6oyjhWnbw96pJHwE
April 01, 2009 - Because both studies ex-
amined only adolescents, no information was found that
is directly applicable … Both of these studies
examined only adolescents, so no information was
found that is directly applicable … We focused on the RD, instead of RR, because the data are
more directly applicable to comparing risks
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/s5tZxonEjD3qZsoj-7Bq5P
May 01, 2014 - Consistent
3 (adverse events) NA 0 0 NA NA
NA � not applicable.
-
www.uspreventiveservicestaskforce.org/uspstf/document/update-on-the-methods-of-the-us-preventive-services-task-force-estimating-certainty-and-magnitude-of-net-bene%EF%AC%81t/carotid-artery-stenosis-screening-december-2007
December 15, 2007 - The Task Force would rate a body of evidence that was not clearly applicable to general practice or has
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/UA7cEG8wH4xh8-fr7Lfw9q
September 18, 2018 - unclear how well patients tolerate these medications and
whether the findings from these trials are applicable
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/L5UwXoftg4JHw4buVDhjUT
October 01, 2010 - screening test; includes a moderate sample size (50–100 persons) and a medium spectrum of patients (i.e., applicable
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/TkWNoq6KQb3SoZ54gscLCQ
July 25, 2016 - , hepatitis B surface antigen;
HBV, hepatitis B virus; HR, hazard ratio; KQ, key question; NA, not applicable